Product NDC: | 0085-1168 |
Proprietary Name: | Intron A |
Non Proprietary Name: | Interferon alfa-2b |
Active Ingredient(s): | 11.6 ug/.5mL & nbsp; Interferon alfa-2b |
Administration Route(s): | INTRAMUSCULAR; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0085-1168 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103132 |
Marketing Category: | BLA |
Start Marketing Date: | 19860604 |
Package NDC: | 0085-1168-01 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0085-1168-01) > 3.8 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0085-1168-01 |
Proprietary Name | Intron A |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0085-1168-01) > 3.8 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0085-1168 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Interferon alfa-2b |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; SUBCUTANEOUS |
Start Marketing Date | 19860604 |
Marketing Category Name | BLA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | INTERFERON ALFA-2B |
Strength Number | 11.6 |
Strength Unit | ug/.5mL |
Pharmaceutical Classes | Interferon Alfa-2b [Chemical/Ingredient],Interferon alpha [EPC],Interferon-alpha [Chemical/Ingredient] |